How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease

Taking stock of the drug industry, from the lab to the medicine chest

June 18, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease The story of its drug says a lot about why medicines are so tough to develop and why heart disease remains the biggest killer in the U.S. By Matthew Herper To treat obesity in children, task force favors behavioral therapy over drugs like Wegovy An influential task force wades into the debate over whether to put children with obesity on drugs like Wegovy. It concludes: wait for data. By Elizabeth Cooney STAT+ | To feed an AI that designs new enzymes, Basecamp hunts rare proteins at the world's end In a new study, Basecamp and Institute of Molecular Biology of Barcelona detail a new AI model called ZymCTRL that designs new enzymes. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser